Description
Product Description
MM-401 (CAS 1442106-10-6) is a small-molecule inhibitor specifically designed to disrupt the MLL1–WDR5 protein-protein interaction, a crucial step in the regulation of histone H3 lysine 4 (H3K4) methylation. This epigenetic mark plays a central role in regulating gene expression, and its dysregulation has been strongly linked to mixed lineage leukemia (MLL) and other cancers.
Background on MLL1 and Epigenetic Regulation
MLL1 (Mixed-Lineage Leukemia 1) is a histone methyltransferase that catalyzes H3K4 methylation, an epigenetic modification associated with transcriptional activation.
MLL1 functions within a multi-protein complex requiring co-factors such as WDR5, RbBP5, and ASH2L.
Dysregulation of MLL1 activity leads to aberrant transcription of genes involved in hematopoietic differentiation and oncogenesis.
Role of MM-401 in Research
Leukemia Studies
MLL-rearranged leukemias are aggressive hematological malignancies with poor prognosis.
MM-401 selectively inhibits leukemic cell growth by targeting MLL1-WDR5 interactions.
Promotes cell cycle arrest, apoptosis, and differentiation of leukemic blasts.
Epigenetic Mechanism Exploration
Serves as a model compound for understanding histone methyltransferase biology.
Helps delineate the role of H3K4 methylation in transcription regulation.
Drug Discovery Tool
Acts as a chemical probe to validate the therapeutic potential of disrupting MLL complexes.
Guides development of next-generation MLL1 inhibitors.
Free Form vs. Salt Form (MM-401 TFA)
Both demonstrate equivalent biological activity at equimolar concentrations.
TFA salt form provides enhanced water solubility and chemical stability, making it more suitable for biological assays.
Product Specifications
| Item | Details |
|---|---|
| Product Name | MM-401 |
| CAS No. | 1442106-10-6 |
| Synonyms | MLL1-WDR5 interaction inhibitor, MM-401 TFA (salt form) |
| Target | MLL1 H3K4 methyltransferase |
| IC50 | 0.32 μM (MLL1-WDR5 disruption) |
| Molecular Type | Small-molecule inhibitor |
| Appearance | Solid powder |
| Purity | ≥95% (HPLC) |
| Solubility | Soluble in DMSO, aqueous buffers (TFA salt more soluble) |
| Storage | -20°C to -80°C, desiccated, protected from light |
| Stability | Stable for 12 months under recommended conditions |
| Applications | Leukemia research, epigenetic regulation, chemical probe studies |
Notes
Supplied in both free and TFA salt forms.
Endotoxin-free.
For research use only.
Mechanism of Action
MM-401 functions by selectively blocking the interaction of MLL1 with WDR5, thereby inhibiting MLL1-mediated methylation of histone H3 at lysine 4 (H3K4).
Disruption of MLL1-WDR5 Interaction
WDR5 is essential for stabilizing MLL1 complex formation.
MM-401 binds to the WDR5 interaction site, preventing recruitment of MLL1.
Inhibition of H3K4 Methylation
Loss of MLL1 activity reduces H3K4 trimethylation.
Leads to downregulation of genes critical for leukemogenesis, such as HOXA9 and MEIS1.
Cell Cycle Arrest
Inhibition of transcriptional programs controlled by MLL1 halts proliferation.
Leukemic cells undergo G0/G1 arrest.
Induction of Apoptosis
Triggered by downregulation of survival genes.
Leads to caspase activation and programmed cell death.
Differentiation of Leukemic Cells
By relieving epigenetic blocks, MM-401 promotes terminal differentiation.
Epigenetic Selectivity
Unlike global histone methyltransferase inhibitors, MM-401 is highly selective for the MLL1-WDR5 interaction.
Minimizes off-target effects and provides a precise research tool.

Side Effects
Research Observations
Demonstrates high selectivity for MLL1-WDR5 with minimal off-target inhibition.
Reduces leukemic cell viability while sparing most normal hematopoietic cells.
Potential Research Risks
Prolonged exposure may alter gene expression landscapes in non-leukemic cells.
Possible cytotoxicity at high concentrations.
Stability of the free form is lower compared to TFA salt.
Laboratory Safety Notes
For laboratory research only.
Handle under sterile conditions.
Store in recommended conditions to preserve activity.
Disclaimer
This product is intended for research purposes only. MM-401 is not approved for clinical or diagnostic use in humans.
Keywords
MM-401, CAS 1442106-10-6, MLL1 inhibitor, WDR5-MLL1 interaction blocker, H3K4 methyltransferase inhibitor, MM-401 TFA, leukemia research compound, epigenetic inhibitor.china low price supplier
Shipping Guarantee
We provide reliable global shipping services:
Customs-Cleared & Tax-Inclusive deliveries.
100% Compensation for any loss or damage in transit.
Trackable and efficient international logistics.
Transaction Guarantee
We support secure and flexible payment methods:
T/T bank transfer
PayPal
Cryptocurrency (BTC, ETH, USDT, etc.)
Additional methods available on request
We ensure safe, transparent, and convenient transactions for all research products.




Reviews
There are no reviews yet.